Add to Calendar

From Molecule to Market: Accelerating the Transformation of Healthcare

Tue, Feb 12, 2019   5:30 PM - 8:30 PM

Pennovation Center, Philadelphia, PA

Philadelphia is leading the way as a pioneer in healthcare innovation and commercialization. Join HBA Philadelphia to learn how new approaches are driving the future of medicine from bench to bedside.

HBA Philadelphia presents

From Molecule to Market: Accelerating the Transformation of Healthcare

Date and time


Event contact

Susan Spitz





Event sponsors

    Please note: This event will still be held despite the inclement weather. If you have any questions or need further assistance, please reach out to the chapter contact.

Now more than ever, Greater Philadelphia is leading the way as a pioneer in healthcare innovation and commercialization. 80 per cent of US pharmaceutical companies have a presence in the region, which also boasts a world-class network of medical research institutions, 15 major health systems, leading clinical research organizations and an expanding investment in biotech.

In 2018, The American Society of Clinical Oncology named CAR-T cell therapy (pioneered here in Philadelphia by a group of scientists, from the University of Pennsylvania) as their “Advance of the Year”. In December of 2017, research in Philadelphia resulted in the FDA’s approval of the first gene therapy in the U.S. to target a disease caused by mutations in a specific gene.

What will 2019 hold?

Join HBA Philadelphia to learn how new approaches to technology transfer and collaborative partnerships are driving the future of medicine and improving health outcomes from the bench to the bedside.

5:30 - 6:30 PM    Networking
6:30 - 6:40 PM    Welcome
6:40 - 8:00 PM    Presentation
8:00 - 8:30 PM    Closing

Special instructions: Casual dress with cushioned, bleacher-seating.

Free parking available inside complex. Please see this map for directions.

Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: 12 February 2019
Onsite (walk-in) registration: Is allowed
    *We do NOT recommend registering onsite unless absolutely necessary. To register onsite, please arrive
      fifteen minutes early and be prepared to use a smartphone or other mobile device to register AND create
      an HBA profile. Payment is due prior to the start of the event and cash is NOT accepted as payment.

This event is refundable. All refund requests must be submitted in writing to by 9 February 2019. No refunds are available after this date.


Featured speakers

Beverly Hoffman, MBA

AstraZeneca Pharmaceuticals LP

Dora Mitchell, PhD

Carisma Therapeutics

Susan Spitz

Incyte Corporation

Heather Steinman, PhD, MBA

The Wistar Institute

Christine Ward, PhD

Bristol-Myers Squibb Company


Learning objectives

1. Identify novel strategies for bringing a drug to market.
2. Have a better understanding of the innovation happening in the Philadelphia area.


Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.


 Registration NamePrice LevelRegular

 1 - Regular registration

 1 - Regular registrationMember$40.00
 1 - Regular registrationMember - Euro€34.00
 1 - Regular registrationNon-Member$60.00
 1 - Regular registrationNon-Member - Euro€51.00

 2 - WIT registration

 2 - WIT registrationMember$25.00
 2 - WIT registrationMember - Euro€21.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.